Thiogenesis Therapeutics Corp. engages in the development of novel drug formulations that act as precursors for rare diseases. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Thiogenesis Therapeutics Corp market cap is $28.77M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Thiogenesis Therapeutics Corp 52 week high is $0.5834 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Thiogenesis Therapeutics Corp 52 week low is $0.2859 as of November 18, 2026.
Thiogenesis Therapeutics Corp stock price today is $0.4111.
Thiogenesis Therapeutics Corp stock price yesterday was $0.3737.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Thiogenesis Therapeutics Corp's P/E ratio is -4.57.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Thiogenesis Therapeutics Corp P/B ratio is 6.0706.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Thiogenesis Therapeutics Corp 50-day moving average is $0.3751.